Back to directory
Advanced imaging agents for early diagnosis of neurodegenerative diseases
Built from URLHealthcareNeuroscienceMedical DevicesBiotechHealthTechDrug Discovery
See something off about this company?
Advanced imaging agents for early diagnosis of neurodegenerative diseases
Built from URLSee something off about this company?
Alzheimer's affects approximately 5.5 million Americans at a cost of over $226 billion in care, with incidence projected to quadruple by 2050. Early detection is critical as disease pathology begins 10-15 years before cognitive symptoms appear.